NPS PHARMACEUTICALS INC
NPSP
NPSP was delisted on the 20th of February, 2015.
215 hedge funds and large institutions have $3.36B invested in NPS PHARMACEUTICALS INC in 2014 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 78 increasing their positions, 69 reducing their positions, and 44 closing their positions.
16% more capital invested
Capital invested by funds: $2.89B → $3.36B (+$465M)
13% more repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 69
11% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 44
2% more funds holding
Funds holding: 210 → 215 (+5)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
12% less call options, than puts
Call options by funds: $72.5M | Put options by funds: $82M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$65.5M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$36.9M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$32.3M |
| 4 |
VAM
Visium Asset Management
New York
|
+$29.5M |
| 5 |
PC
PointState Capital
New York
|
+$24.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
RS Investment Management
San Francisco,
California
|
-$45.8M |
| 2 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$29.9M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$21.8M |
| 4 |
CCM
Century Capital Management
Boston,
Massachusetts
|
-$17.2M |
| 5 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
-$14.2M |
NPSP Hedge Fund Activity: Q2 2014 in Review
215 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in NPS PHARMACEUTICALS INC (NPSP) for Q2 2014, worth a combined $3.36B — up 16% from $2.89B a quarter earlier.
Buyers outnumbered sellers: 49 funds opened new NPSP positions and 44 closed out — a net gain of 5 holders — while 78 added to existing stakes and 69 trimmed.
The largest buyer was Wells Fargo, adding an estimated $65.5M. The largest seller was RS Investment Management, exiting entirely with an estimated $45.8M sold.
- 215 institutional investors held NPS PHARMACEUTICALS INC (NPSP) as of Q2 2014, up from 210 in Q1 2014.
- Funds reported $3.36B of NPS PHARMACEUTICALS INC stock for Q2 2014, up 16% quarter-over-quarter.
- 49 funds opened new NPS PHARMACEUTICALS INC positions in Q2 2014 and 44 closed out, a net change of +5 holders.
- The largest NPS PHARMACEUTICALS INC buyer in Q2 2014 was Wells Fargo, an estimated $65.5M added.
- The largest NPS PHARMACEUTICALS INC seller in Q2 2014 was RS Investment Management, an estimated $45.8M sold.
Based on aggregated 13F filings for Q2 2014.